Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9426037 | 0.79 | ALDH1A1 (0.58) | ALDH1A1LMNAALOX12MAPTGAA | |
| SCHEMBL9426354 | 0.77 | ALDH1A1 (0.59) | ALDH1A1LMNAALOX12MAPTGAA | |
| SCHEMBL9425866 | 0.77 | ALDH1A1 (0.59) | ALDH1A1LMNAALOX12MAPTGAA | |
| SCHEMBL9425921 | 0.76 | ALDH1A1 (0.54) | ALDH1A1LMNAALOX12GAAHTT | |
| SCHEMBL9425868 | 0.76 | ALDH1A1 (0.54) | ALDH1A1LMNAALOX12MAPTGAA | |
| SCHEMBL9426543 | 0.73 | ALDH1A1 (0.54) | ALDH1A1LMNAALOX12MAPTGAA | |
| SCHEMBL16666104 | 0.73 | ALDH1A1 (0.58) | ALDH1A1LMNAALOX12MAPTGAA | |
| SCHEMBL9426466 | 0.73 | ALDH1A1 (0.51) | ALDH1A1LMNAALOX12MAPTGAA | |
| SCHEMBL9426269 | 0.72 | ALDH1A1 (0.63) | ALDH1A1LMNAALOX12MAPTGAA | |
| Hydrochloric Acid SCHEMBL9426281 | 0.71 | ALDH1A1 (0.62) | ALDH1A1LMNAALOX12MAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5371086-A | Circulatory disorders side effect reduction | THE GREEN CROSS CORPORATION (JP) | 1994-12-06 | — | — | US | disclosed |
| US-5262415-A | FOR TREATING DISEASES OF THE CIRCULATORY SYSTEM | THE GREEN CROSS CORPORATION (JP) | 1993-11-16 | — | — | US | disclosed |
| EP-0503627-A1 | Aminopyridine compounds | THE GREEN CROSS CORPORATION (JP) | 1992-09-16 | — | — | EP | disclosed |